Ayrton Capital's passive 9.99% warrant-based stake adds to existing similar positions by Intracoastal Capital and Susquehanna. Monitor for any conversion to SC 13D or exercise of warrants, which could signal a shift from passive to active intent.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 12 $1.56entry
- T+1 · 4d ago +4.49%α +4.85% · $1.63
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Ayrton Capital LLC filed a new Schedule 13G disclosing beneficial ownership of 103,250 American Depositary Shares (each representing 2,000 ordinary shares) of Purple Biotech Ltd., representing 9.99% of outstanding common stock as of September 30, 2026. The shares are issuable upon exercise of warrants subject to a 9.99% beneficial ownership blocker. The filing certifies passive intent with no control-related purpose.
Key Financial Metrics
Key Facts
- Ayrton Capital LLC, along with Alto Opportunity Master Fund and Waqas Khatri, filed a new SC 13G disclosing a 9.99% beneficial ownership stake in Purple Biotech Ltd.
- The stake consists of 103,250 shares of common stock issuable upon exercise of warrants, subject to a 9.99% beneficial ownership blocker.
- The filing certifies passive intent under Rule 13d-1(b) with no purpose of changing or influencing control.
- The percentage is based on 929,456 shares outstanding as of December 31, 2025, per the issuer's Form 20-F filed March 19, 2026.
- Prior SC 13G/A filings by Intracoastal Capital LLC (also 9.99% warrant-based) and Susquehanna Securities were filed in August and May 2026.
Financial Impact
9.99% beneficial ownership via warrants; no cash value stated in filing
Risk Factors
- Warrant exercise could increase share count and dilute existing holders
- Multiple passive holders at the 9.99% blocker level may indicate coordinated interest; any future 13D conversion would be a material event
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001493152-26-051281 |
| Document: 0001493152-26-051281-index.html | 0001493152-26-051281 |
| Document: 0001493152-26-051281.txt | 0001493152-26-051281 |
Track record
14 reports on PPBT
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago SC 13G Neutral 3/10 Viewing Entry $1.56 Now $1.68 +7.69% settles Feb 10
- Nov 12, 20265d ago EFFECT Neutral 3/10 Entry $1.56 Now $1.68 +7.69% settles Feb 10
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $1.49 Now $1.68 +12.75% settles Feb 9
- Oct 29, 202618d ago Press Release Neutral 3/10 Entry $1.09 Now $1.68 +54.13% settles Jan 27
- Oct 5, 20266w ago 6-K Neutral 2/10 Entry $1.47 Now $1.68 +14.29% settles Dec 31
- Sep 9, 20269w ago 6-K Neutral 2/10 Entry $1.74 Now $1.68 −3.45% settles Dec 4
- Sep 2, 202610w ago 6-K Neutral 3/10 Entry $1.98 Now $1.68 −15.15% settles Nov 27
- Aug 10, 202614w ago 6-K Neutral 4/10 Entry $1.55 to $1.22 Now $1.68 +8.39% ▼ −21.61% −21.13% vs SPY
- Aug 7, 202614w ago 6-K Neutral 4/10 Entry $1.43 to $1.22 Now $1.68 +17.48% ▼ −14.69% −12.55% vs SPY
- May 15, 202626w ago Press Release Neutral 4/10 Entry $3.94 to $1.55 Now $1.68 −57.36% ▼ −60.66% −65.18% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers